Aclarion, Inc. SEC filings ACON
Aclarion, Inc. has 276 filings in SEC EDGAR's recent list, going back to Mar 3, 2015. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jun 4, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 4, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2026 | Jun 4, 2026 |
| DEFA14A | Additional proxy material | Jul 7, 2025 | — |
| DEF 14A | Proxy statement | May 13, 2025 | Jul 7, 2025 |
| PRE 14A | Preliminary proxy statement | May 2, 2025 | Jul 31, 2025 |
| DEFA14A | Additional proxy material | Feb 28, 2025 | — |
| DEF 14A | Proxy statement | Feb 3, 2025 | Feb 28, 2025 |
| PRE 14A | Preliminary proxy statement | Jan 22, 2025 | Feb 28, 2025 |
| DEF 14A | Proxy statement | Dec 2, 2024 | Dec 31, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 22, 2024 | Nov 22, 2024 |
| DEF 14A | Proxy statement | Aug 26, 2024 | Sep 23, 2024 |
| PRE 14A | Preliminary proxy statement | Aug 16, 2024 | Aug 16, 2024 |
| DEF 14A | Proxy statement | Nov 13, 2023 | Dec 18, 2023 |
| PRE 14A | Preliminary proxy statement | Nov 1, 2023 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Feb 27, 2023 | Mar 24, 2023 |
| PRE 14A | Preliminary proxy statement | Feb 14, 2023 | Mar 15, 2023 |
Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- ACON (Nasdaq), ACONW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Broomfield, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1635077
- Former names
- Nocimed, Inc. (until Oct 26, 2021)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.